{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:45:00Z","timestamp":1770677100679,"version":"3.49.0"},"reference-count":316,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T00:00:00Z","timestamp":1354924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s10741-012-9362-7","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T07:44:26Z","timestamp":1354866266000},"page":"761-795","source":"Crossref","is-referenced-by-count":40,"title":["Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives"],"prefix":"10.1007","volume":"18","author":[{"given":"Bernhard","family":"Maisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Pankuweit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,8]]},"reference":[{"key":"9362_CR1","first-page":"369","volume":"2","author":"WW Kerr","year":"1904","unstructured":"Kerr WW (1904) Myocarditis. Cal State J Med 2:369\u2013371","journal-title":"Cal State J Med"},{"key":"9362_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.hfc.2011.08.014","volume":"8","author":"B Maisch","year":"2012","unstructured":"Maisch B, Noutsias M, Ruppert V, Richter A, Pankuweit S (2012) Cardiomyopathies\u2014classifications, diagnosis, and treatment. Heart Fail Clin 8:53\u201378. doi: 10.1016\/jhfc.2011.08.014","journal-title":"Heart Fail Clin"},{"key":"9362_CR3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/imj.1960.9.4.258","volume":"9","author":"JB Hickie","year":"1960","unstructured":"Hickie JB, Hall GV (1960) The cardiomyopathies: a report of fifty cases. Australas Ann Med 9:258\u2013270","journal-title":"Australas Ann Med"},{"key":"9362_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/bmj.1.5219.69","volume":"1","author":"JF Goodwin","year":"1961","unstructured":"Goodwin JF, Gordon H, Hollman A et al (1961) Clinical aspects of cardiomyopathy. Br Med J 1:69\u201379.5","journal-title":"Br Med J"},{"key":"9362_CR5","doi-asserted-by":"crossref","unstructured":"Report of the WHO\/ISFC (1980) Task Force on the definition and classification of cardiomyopathies. Br Heart J 44:672\u2013674","DOI":"10.1136\/hrt.44.6.672"},{"key":"9362_CR6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M, Maisch B et al (1996) Report of the 1995 World Health Organization\/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93:841\u2013842","journal-title":"Circulation"},{"key":"9362_CR7","doi-asserted-by":"crossref","unstructured":"Maisch B, Pankuweit S (2012) Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy. Herz 37:644\u2013656. doi: 10.1007\/s00059-012-3679-9","DOI":"10.1007\/s00059-012-3679-9"},{"key":"9362_CR8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0046-8177(87)80363-5","volume":"18","author":"HT Aretz","year":"1987","unstructured":"Aretz HT, Billingham M, Olsen E et al (1987) Myocarditis: the Dallas criteria. Hum Pathol 18:619\u2013624","journal-title":"Hum Pathol"},{"key":"9362_CR9","first-page":"3","volume":"4","author":"B Maisch","year":"1999","unstructured":"Maisch B, B\u00fcltman B, Factor S et al (1999) World Heart Federation consensus conference\u2019s definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat 4:3\u20134","journal-title":"Heartbeat"},{"key":"9362_CR10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s000590050007","volume":"25","author":"B Maisch","year":"2000","unstructured":"Maisch B, Portig I, Ristic A et al (2000) Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. Herz 25:200\u2013209","journal-title":"Herz"},{"key":"9362_CR11","doi-asserted-by":"crossref","unstructured":"Maisch B, Richter A, Sandm\u00f6ller A, Portig I, Pankuweit S (2005) for the members of project 9a in the BMBF-Heart Failure Network. Inflammatory dilated cardiomyopathy (DCMI). Herz 30:535\u2013540","DOI":"10.1007\/s00059-005-2730-5"},{"key":"9362_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s000590050010","volume":"25","author":"S Pankuweit","year":"2000","unstructured":"Pankuweit S, Portig I, Eckhardt H et al (2000) Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz 25:221\u2013226","journal-title":"Herz"},{"issue":"20","key":"9362_CR13","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","volume":"28","author":"WJ Paulus","year":"2007","unstructured":"Paulus WJ, Tsch\u00f6pe C, Sanderson JE et al (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European society of cardiology. Eur Heart J 28(20):2539\u20132555","journal-title":"Eur Heart J"},{"key":"9362_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/321978","volume":"69","author":"E Arbustini","year":"2001","unstructured":"Arbustini E, Morbini P, Pilotto A et al (2001) Familial dilated cardiomyopathy: from clinical presentation to molecular genetics. Am J Hum Genet 69:249\u2013260","journal-title":"Am J Hum Genet"},{"key":"9362_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0008-6363(03)00437-1","volume":"60","author":"JW Mason","year":"2003","unstructured":"Mason JW (2003) Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60:5\u201310","journal-title":"Cardiovasc Res"},{"key":"9362_CR16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0140-6736(02)09879-3","volume":"360","author":"T Shaw","year":"2002","unstructured":"Shaw T, Elliot P, McKenna WJ (2002) Dilated cardiomyopathy: a genetically heterogeneous disease. Lancet 360:654\u2013655","journal-title":"Lancet"},{"key":"9362_CR17","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807\u20131816","journal-title":"Circulation"},{"key":"9362_CR18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 29:270\u2013276","journal-title":"Eur Heart J"},{"key":"9362_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00059-009-3195-8","volume":"34","author":"S Pankuweit","year":"2009","unstructured":"Pankuweit S, Richter A, Ruppert V et al (2009) Classification of cardiomyopathies and indication for endomyocardial biopsy revisited. Herz 34:55\u201362","journal-title":"Herz"},{"issue":"2","key":"9362_CR20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/euhj.1998.1145","volume":"20","author":"L Mestroni","year":"1999","unstructured":"Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, Tesson F, Richter A, Wilke A, Komajda M (1999) Guidelines for the study of familial dilated cardiomyopathies. Collaborative research group of the European human and capital mobility project on familial dilated cardiomyopathy. Eur Heart J 20(2):93\u2013102","journal-title":"Eur Heart J"},{"issue":"3","key":"9362_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCHEARTFAILURE.108.817346","volume":"2","author":"RE Hershberger","year":"2009","unstructured":"Hershberger RE, Cowan J, Morales A, Siegfried JD (2009) Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Circ Heart Fail 2(3):253\u2013261","journal-title":"Circ Heart Fail"},{"issue":"Suppl. A","key":"9362_CR22","doi-asserted-by":"crossref","first-page":"A-38","DOI":"10.1253\/circj.CJ-08-0050","volume":"72","author":"A Kimura","year":"2008","unstructured":"Kimura A (2008) Molecular aetiology and pathogenesis of hereditary cardiomyopathy. Circ J 72(Suppl. A):A-38\u2013A-48","journal-title":"Circ J"},{"issue":"17","key":"9362_CR23","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/eurheartj\/ehp225","volume":"30","author":"L Duboscq-Bidot","year":"2009","unstructured":"Duboscq-Bidot L, Charron P, Ruppert V, Fauchier L, Richter A, Tavazzi L, Arbustini E, Wichter T, Maisch B, Komajda M, Isnard R (2009) EUROGENE Heart Failure Network. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J 30(17):2128\u20132136","journal-title":"Eur Heart J"},{"issue":"1","key":"9362_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/CIRCULATIONAHA.106.670554","volume":"115","author":"Y Maekawa","year":"2007","unstructured":"Maekawa Y, Ouzounian M, Opavsky MA, Liu PP (2007) Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation 115(1):5\u20138","journal-title":"Circulation"},{"issue":"1","key":"9362_CR25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cardiores.2006.08.009","volume":"73","author":"A Linde","year":"2007","unstructured":"Linde A, Mosier D, Blecha F, Melgarejo T (2007) Innate immunity and inflammation\u2014new frontiers in comparative cardiovascular pathology. Cardiovasc Res 73(1):26\u201336","journal-title":"Cardiovasc Res"},{"issue":"9","key":"9362_CR26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.110.226936","volume":"108","author":"DL Mann","year":"2011","unstructured":"Mann DL (2011) The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res 108(9):1133\u20131145","journal-title":"Circ Res"},{"key":"9362_CR27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00059-006-2941-4","volume":"31","author":"B Maisch","year":"2006","unstructured":"Maisch B, Richter A, Koelsch S et al (2006) Management of patients with suspected (peri-)myocarditis and inflammatory dilated cardiomyopathy. Herz 31:881\u2013890","journal-title":"Herz"},{"key":"9362_CR28","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","volume":"116","author":"LT Cooper","year":"2007","unstructured":"Cooper LT, Baughman KL, Feldman AM, for the American Heart Association, American College of Cardiology, and European Society of Cardiology et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116:2216\u20132233","journal-title":"Circulation"},{"key":"9362_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0046-8177(03)00078-9","volume":"34","author":"S Pankuweit","year":"2003","unstructured":"Pankuweit S, Moll R, Baandrup U, Portig I, Hufnagel G, Maisch B (2003) Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol 34:497\u2013500","journal-title":"Hum Pathol"},{"key":"9362_CR30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","volume":"11","author":"U K\u00fchl","year":"2005","unstructured":"K\u00fchl U, Pauschinger M, Noutsias M et al (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201eidiopathic\u201cleft ventricular dysfunction. Circulation 11:887\u2013893","journal-title":"Circulation"},{"key":"9362_CR31","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1086\/648074","volume":"49","author":"F K\u00fcthe","year":"2009","unstructured":"K\u00fcthe F, Lindner J, Matwschke K, Wenzel JJ, Norja P, Ploetze K, Schaal S, Kamvissi V, Bornstein SR, Schwandebeck U, Modrow S (2009) Prevalence of parvovirus B19 and human Bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 49:1660\u20131666","journal-title":"Clin Infect Dis"},{"issue":"1","key":"9362_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.110.958249","volume":"4","author":"GC Stewart","year":"2011","unstructured":"Stewart GC, Lopez-Molina J, Gottumukkala RV, Rosner GF, Anello MS, Hecht JL, Winters GL, Padera RF, Baughman KL, Lipes MA (2011) Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ Heart Fail 4(1):71\u201378","journal-title":"Circ Heart Fail"},{"key":"9362_CR33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00059-002-2373-8","volume":"27","author":"B Maisch","year":"2002","unstructured":"Maisch B, Ristic AD, Hufnagel G et al (2002) Dilated cardiomyopathies as a cause of congestive heart failure. Herz 27:113\u2013134","journal-title":"Herz"},{"key":"9362_CR34","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.2741\/962","volume":"8","author":"B Maisch","year":"2003","unstructured":"Maisch B, Ristic AD, Portig I, Pankuweit S (2003) Human viral cardiomyopathy. Front Biosci 8:S39\u2013S67","journal-title":"Front Biosci"},{"issue":"Suppl. B","key":"9362_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/eurheartj\/12.suppl_D.81","volume":"12","author":"B Maisch","year":"1991","unstructured":"Maisch B, Outzen H, Roth D, Hiby A, Herzum M, Hengstenberg C, Hufnagel G, Sch\u00f6nian U, Kochsiek K (1991) Prognostic determinants in conventionally treated myocarditis and perimyocarditis-Focus on antimyolemmal antibodies. Eur Heart J 12(Suppl. B):81\u201387","journal-title":"Eur Heart J"},{"key":"9362_CR36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.108.769489","volume":"118","author":"I Kindermann","year":"2008","unstructured":"Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, Lindinger A, Boehm M (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639\u2013648","journal-title":"Circulation"},{"key":"9362_CR37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00059-007-3046-4","volume":"32","author":"J Schulz-Menger","year":"2007","unstructured":"Schulz-Menger J, Maisch B, Abdel-Aty H et al (2007) Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers. A stepwise approach for diagnosis and treatment. Herz 32:458\u2013472","journal-title":"Herz"},{"key":"9362_CR38","first-page":"8","volume":"10","author":"B Maisch","year":"1985","unstructured":"Maisch B, B\u00fclowius U, Schmier K, Klopf D, Koper D, Sibelis T, Kochsiek K (1985) Immunological cellular regulator and effector mechanisms in myocarditis. Herz 10:8\u201314","journal-title":"Herz"},{"issue":"5","key":"9362_CR39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01476967","volume":"58","author":"B Maisch","year":"1980","unstructured":"Maisch B, Berg PA, Kochsiek K (1980) Autoantibodies and serum inhibition factors (SIF) in patients with myocarditis. Klin Wochenschr 58(5):219\u2013225","journal-title":"Klin Wochenschr"},{"key":"9362_CR40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0022-1759(81)90343-4","volume":"44","author":"B Maisch","year":"1981","unstructured":"Maisch B, Trostel-Soeder R, Berg PA, Kochsiek K (1981) Assessment of antibody mediated cytolysis of vital adult cardiocytes isolated by centrifugation in a continuous gradient of Percoll TM in patients with acute myocarditis. J Immunol Methods 44:159\u2013169","journal-title":"J Immunol Methods"},{"key":"9362_CR41","first-page":"533","volume":"48","author":"B Maisch","year":"1982","unstructured":"Maisch B, Trostel-Soeder R, Stechemesser E, Berg PA, Kochsiek K (1982) Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol 48:533\u2013545","journal-title":"Clin Exp Immunol"},{"key":"9362_CR42","first-page":"149","volume":"88","author":"B Maisch","year":"1993","unstructured":"Maisch B, Herzum M, Sch\u00f6nian U (1993) Immunomodulating factors and immunosuppressive drugs in the therapy of myocarditis. Scand J Infect Dis 88:149\u2013162","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"9362_CR43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1054-8807(01)00113-2","volume":"11","author":"B Maisch","year":"2002","unstructured":"Maisch B, Ristic AD, Hufnagel G, Pankuweit S (2002) Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc Pathol 11(2):112\u2013122","journal-title":"Cardiovasc Pathol"},{"issue":"Suppl. 1","key":"9362_CR44","first-page":"47","volume":"80","author":"B Maisch","year":"1985","unstructured":"Maisch B (1985) Surface antigens of adult heart cells and their use in diagnosis. Basic Res Cardiol 80(Suppl. 1):47\u201352","journal-title":"Basic Res Cardiol"},{"issue":"Suppl. I","key":"9362_CR45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/eurheartj\/8.suppl_J.155","volume":"8","author":"B Maisch","year":"1987","unstructured":"Maisch B (1987) The sarcolemma as antigen in the secondary immunopathogenesis of myopericarditis. Eur Heart J 8(Suppl. I):155\u2013165","journal-title":"Eur Heart J"},{"issue":"Suppl. 3","key":"9362_CR46","first-page":"101","volume":"86","author":"B Maisch","year":"1991","unstructured":"Maisch B, Drude L, Hengstenberg C, Herzum M, Hufnagel G, Kochsiek K, Schmaltz A, Sch\u00f6nian U, Schwab D (1991) Are antisarcolemmal(ASAs) and antimyolemmal antibodies(AMLAs) \u201cnatural\u201d antibodies? Basic Res Cardiol 86(Suppl. 3):101\u2013114","journal-title":"Basic Res Cardiol"},{"issue":"Suppl. 1","key":"9362_CR47","first-page":"11","volume":"68","author":"B Maisch","year":"1992","unstructured":"Maisch B, Drude L, Hengstenberg C, Hufnagel G, Sch\u00f6nian U, Schwab D (1992) Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis. Postgrad Med J 68(Suppl. 1):11\u201316","journal-title":"Postgrad Med J"},{"issue":"Suppl. IV","key":"9362_CR48","first-page":"49","volume":"87","author":"B Maisch","year":"1993","unstructured":"Maisch B, Bauer E, Cirsi M, Kochsiek K (1993) Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. Circulation 87(Suppl. IV):49\u201365","journal-title":"Circulation"},{"key":"9362_CR49","first-page":"369","volume":"11","author":"B Maisch","year":"1989","unstructured":"Maisch B (1989) Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury. Springer Semin Immunopathol 11:369\u2013396","journal-title":"Springer Semin Immunopathol"},{"key":"9362_CR50","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/0002-9149(83)90535-0","volume":"52","author":"B Maisch","year":"1983","unstructured":"Maisch B, Deeg P, Liebau G, Kochsiek K (1983) Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 52:1072\u20131078","journal-title":"Am J Cardiol"},{"issue":"Suppl. I","key":"9362_CR51","first-page":"223","volume":"8","author":"B Maisch","year":"1987","unstructured":"Maisch B, Wedeking U, Kochsiek K (1987) Quantitative assessment of antilaminin antibodies in myocarditis and perimyocarditis. Eur Heart J 8(Suppl. I):223\u2013235","journal-title":"Eur Heart J"},{"issue":"Suppl. I","key":"9362_CR52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/eurheartj\/8.suppl_J.181","volume":"8","author":"U Obermayer","year":"1987","unstructured":"Obermayer U, Scheidler J, Maisch B (1987) Antibodies against micro- and intermediate filaments in carditis and dilated cardiomyopaty\u2014are they a diagnostic marker? Eur Heart J 8(Suppl. I):181\u2013186","journal-title":"Eur Heart J"},{"key":"9362_CR53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0022-1759(83)90402-7","volume":"64","author":"B Wittner","year":"1983","unstructured":"Wittner B, Maisch B, Kochsiek K (1983) Quantification of antimyosin antibodies in experimental myocarditis by a new solidphase fluorometric assay. J Immunol Methods 64:239\u2013247","journal-title":"J Immunol Methods"},{"key":"9362_CR54","first-page":"283","volume":"58","author":"R Klein","year":"1984","unstructured":"Klein R, Maisch B, Kochsiek K, Berg PA (1984) Demonstration of organ specific antibodies against heart mitochondria (anti M7) in sera from patients with some forms of heart diseases. J Clin Exp Immunol 58:283\u2013292","journal-title":"J Clin Exp Immunol"},{"key":"9362_CR55","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0022-2828(85)80029-8","volume":"17","author":"HP Schultheiss","year":"1988","unstructured":"Schultheiss HP, Bolte HD (1988) Immunological analysis of autoantibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 17:603\u2013617","journal-title":"J Mol Cell Cardiol"},{"key":"9362_CR56","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0002-9149(97)00600-0","volume":"80","author":"K Pohlner","year":"1997","unstructured":"Pohlner K, Portig I, Pankuweit S, Lottspeich F, Maisch B (1997) Identification of mitochondrial antigens recognized by the antibodies in sera of patients with dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol 80:1040\u20131045","journal-title":"Am J Cardiol"},{"key":"9362_CR57","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0002-9149(97)00600-0","volume":"80","author":"S Pankuweit","year":"1997","unstructured":"Pankuweit S, Pohlner K, Lottspeich F et al (1997) Identification of mitochondrial antigens recognized by antibodies in sera of patients with dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol 80:1040\u20131045","journal-title":"Am J Cardiol"},{"key":"9362_CR58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/jmcc.1996.0253","volume":"29","author":"S Pankuweit","year":"1997","unstructured":"Pankuweit S, Portig I, Lottspeich F et al (1997) Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 29:77\u201384","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"9362_CR59","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1006\/jmcc.1997.0463","volume":"29","author":"I Portig","year":"1997","unstructured":"Portig I, Pankuweit S, Maisch B (1997) Antibodies against stressproteins in the sera of patient with dilated cardiomyopathy. J Mol Cell Cardiol 29(8):2245\u20132251","journal-title":"J Mol Cell Cardiol"},{"key":"9362_CR60","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/S0022-2828(08)80036-3","volume":"27","author":"G Wallukat","year":"1995","unstructured":"Wallukat G, Wollenberg A, Morwinski R, Pitschner HF (1995) Anti-beta1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J Mol Cell Cardiol 27:3977\u20134006","journal-title":"J Mol Cell Cardiol"},{"key":"9362_CR61","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1161\/01.CIR.89.6.2760","volume":"89","author":"Y Magnusson","year":"1994","unstructured":"Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta1-adrenoceptor with positive chronotropic effect. Circulation 89:2760\u20132767","journal-title":"Circulation"},{"key":"9362_CR62","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1006\/jmcc.2001.1414","volume":"33","author":"T Christ","year":"2001","unstructured":"Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U (2001) Autoantibodies against the beta1-adrenoceptor from patients with dilated cadiomyopathy prolong action ptoential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 33:1515\u20131525","journal-title":"J Mol Cell Cardiol"},{"key":"9362_CR63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.CIR.99.5.649","volume":"99","author":"R Jahns","year":"1999","unstructured":"Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F (1999) Autoantibodies activating human beta 1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 99:649\u2013654","journal-title":"Circulation"},{"key":"9362_CR64","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI200420149","volume":"113","author":"R Jahns","year":"2004","unstructured":"Jahns R, Bolvin V, Hein L et al (2004) Direct evidence for a beta1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419\u20131429","journal-title":"J Clin Invest"},{"key":"9362_CR65","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1172\/JCI116416","volume":"91","author":"LXM Fu","year":"1993","unstructured":"Fu LXM, Magnusson Y, Bergh CH, Waagstein F, Hjalmarson A, Hoebeke J (1993) Localization of a functional autoimmune epitope on the second extracellular loop of the human muscarinic actylcholin receptor 2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91:1964\u20131968","journal-title":"J Clin Invest"},{"issue":"Part II","key":"9362_CR66","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1540-8159.1986.tb06677.x","volume":"9","author":"B Maisch","year":"1986","unstructured":"Maisch B, Lotze U, Schneider J, Kochsiek K (1986) Antibodies to human sinus node in sick-sinus syndrome. Pace 9(Part II):1101\u20131109","journal-title":"Pace"},{"key":"9362_CR67","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00201879","volume":"11","author":"U Lotze","year":"1989","unstructured":"Lotze U, Maisch B (1989) Humoral immune response to cardiac conducting tissue. Springer Semin Immunopathol 11:409\u2013422","journal-title":"Springer Semin Immunopathol"},{"key":"9362_CR68","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/0735-1097(90)92821-I","volume":"15","author":"ALP Caforio","year":"1990","unstructured":"Caforio ALP, Bonifacio E, Stewart JT et al (1990) Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 15:1527\u20131534","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR69","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(94)92339-6","volume":"344","author":"ALP Caforio","year":"1994","unstructured":"Caforio ALP, Keeling PJ, Zachara E et al (1994) Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 344:773\u2013777","journal-title":"Lancet"},{"key":"9362_CR70","first-page":"207","volume":"21","author":"B Maisch","year":"1996","unstructured":"Maisch B (1996) Alkohol und Herz. Herz 21:207\u2013212","journal-title":"Herz"},{"key":"9362_CR71","first-page":"227","volume":"21","author":"V Menz","year":"1996","unstructured":"Menz V, Grimm W, Hoffmann J, Maisch B (1996) Alcohol and rhythm disturbance: the holiday heart syndrome. Herz 21:227\u2013231","journal-title":"Herz"},{"key":"9362_CR72","first-page":"258","volume":"21","author":"H Rupp","year":"1996","unstructured":"Rupp H, Brilla CG, Maisch B (1996) Hypertonie und Alkohol: zentrale und periphere Mechnismen. Herz 21:258\u2013264","journal-title":"Herz"},{"key":"9362_CR73","first-page":"248","volume":"21","author":"A Wilke","year":"1996","unstructured":"Wilke A, Kaiser A, Ferency I, Maisch B (1996) Alkohol und Myokarditis. Herz 21:248\u2013257","journal-title":"Herz"},{"issue":"9","key":"9362_CR74","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.amjmed.2008.03.046","volume":"121","author":"A Aneja","year":"2008","unstructured":"Aneja A, Tang WH, Bansilal S et al (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121(9):748\u2013757","journal-title":"Am J Med"},{"key":"9362_CR75","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","volume":"26","author":"AG Bertoni","year":"2003","unstructured":"Bertoni AG, Tsai A, Kasper EK, Brancati FL (2003) Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 26:2791\u20132795","journal-title":"Diabetes Care"},{"issue":"3","key":"9362_CR76","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00059-006-2805-y","volume":"31","author":"B Maisch","year":"2006","unstructured":"Maisch B (2006) Obesity, diabetes mellitus and metabolic syndrome: the implications for heart and the vascular system. Herz 31(3):185\u2013188","journal-title":"Herz"},{"key":"9362_CR77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00059-011-3429-4","volume":"36","author":"B Maisch","year":"2011","unstructured":"Maisch B, Alter P, Pankuweit S (2011) Diabetic cardiomyopathy\u2014fact or fiction? Herz 36:102\u2013115","journal-title":"Herz"},{"issue":"Suppl. 4","key":"9362_CR78","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/rheumatology\/kel316","volume":"45","author":"M Matucci-Cerinic","year":"2006","unstructured":"Matucci-Cerinic M, Seferovic PM (2006) Heart involvement in autoimmune rheumatic diseases: the \u2018\u2018phantom of the opera\u2019\u2019. Rheumatology (Oxford) 45(Suppl. 4):iv1\u2013iv3","journal-title":"Rheumatology (Oxford)"},{"key":"9362_CR79","first-page":"81","volume-title":"Rheumatology, vol 16","author":"B Maisch","year":"1992","unstructured":"Maisch B (1992) The heart in rheumatic disease. Rheumatic diseases and sport. In: Baenkler HW (ed) Rheumatology, vol 16. Karger, Basel, pp 81\u2013117"},{"issue":"Suppl. 4","key":"9362_CR80","doi-asserted-by":"crossref","first-page":"iv32","DOI":"10.1093\/rheumatology\/kel307","volume":"45","author":"B Maisch","year":"2006","unstructured":"Maisch B, Pankuweit S, Karatolios K, Risti\u0107 AD (2006) Invasive techniques\u2014from diagnosis to treatment. Rheumatology (Oxford) 45(Suppl. 4):iv32\u2013iv38","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 4","key":"9362_CR81","doi-asserted-by":"crossref","first-page":"iv26","DOI":"10.1093\/rheumatology\/kel309","volume":"45","author":"R Maksimovi\u0107","year":"2006","unstructured":"Maksimovi\u0107 R, Seferovi\u0107 PM, Risti\u0107 AD, Vujisi\u0107-Te\u0161i\u0107 B, Simeunovi\u0107 DS, Radovanovi\u0107 G, Matucci-Cerinic M, Maisch B (2006) Cardiac imaging in rheumatic diseases. Rheumatology (Oxford) 45(Suppl. 4):iv26\u2013iv31","journal-title":"Rheumatology (Oxford)"},{"key":"9362_CR82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"1997","unstructured":"Jacobson DL, Gange SJ, Rose NR et al (1997) Epidemiology and estimated population burden of selected autoimmune disease in the United States. Clin Immunol Immunopathol 84:223\u2013243","journal-title":"Clin Immunol Immunopathol"},{"key":"9362_CR83","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","volume":"2","author":"CC Whittacre","year":"2001","unstructured":"Whittacre CC (2001) Sex differences in autoimmune disease. Nat Immunol 2:777\u2013780","journal-title":"Nat Immunol"},{"issue":"6","key":"9362_CR84","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00059-005-2713-6","volume":"30","author":"I Portig","year":"2005","unstructured":"Portig I, Sandmoller A, Pankuweit S, Maisch B (2005) Women and autoimmune diseases with cardiovascular manifestations. Herz 30(6):522\u2013526","journal-title":"Herz"},{"issue":"Suppl. I","key":"9362_CR85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/eurheartj\/8.suppl_J.59","volume":"8","author":"G Hufnagel","year":"1987","unstructured":"Hufnagel G, Maisch B, Pfeiffer U (1987) Immunhistologic investigations in suspected cardiac sarcoidosis. Eur Heart J 8(Suppl. I):59\u201362","journal-title":"Eur Heart J"},{"issue":"Suppl. I","key":"9362_CR86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/eurheartj\/8.suppl_J.63","volume":"8","author":"B Maisch","year":"1987","unstructured":"Maisch B, Selmayer N, Brugger E, Ertl G, Eilles C, Heinrich J, Gerhards W, Hufnagel G, Schmidt M, Kochsiek K (1987) Cardiac sarcoidosis\u2014clinical and immunoserologic studies. Eur Heart J 8(Suppl. I):63\u201371","journal-title":"Eur Heart J"},{"issue":"12","key":"9362_CR87","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/hc1202.104524","volume":"105","author":"M Schoppet","year":"2002","unstructured":"Schoppet M, Pankuweit S, Moll R, Baandrup U, Maisch B (2002) Images in cardiovascular medicine. Phenotype of infiltrating T lymphocytes in cardiac sarcoidosis. Circulation 105(12):e67\u2013e68","journal-title":"Circulation"},{"issue":"9","key":"9362_CR88","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.5858\/2003-127-1207-CSCPIT","volume":"127","author":"M Schoppet","year":"2003","unstructured":"Schoppet M, Pankuweit S, Maisch B (2003) Cardiac sarcoidosis: cytokine patterns in the course of the disease. Arch Pathol Lab Med 127(9):1207\u20131210","journal-title":"Arch Pathol Lab Med"},{"key":"9362_CR89","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470-511.2000","volume":"13","author":"MW Cunningham","year":"2000","unstructured":"Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470\u2013511","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"9362_CR90","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2249.2000.01283.x","volume":"121","author":"D Tontsch","year":"2000","unstructured":"Tontsch D, Pankuweit S, Maisch B (2000) Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis. Clin Exp Immunol 121(2):270\u2013274","journal-title":"Clin Exp Immunol"},{"key":"9362_CR91","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.4049\/jimmunol.175.8.5448","volume":"175","author":"NM Ellis","year":"2005","unstructured":"Ellis NM, Li Y, Hildebrand W, Fischetti VA, Cunningham MW (2005) T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease. J Immunol 175:5448\u20135456","journal-title":"J Immunol"},{"key":"9362_CR92","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaut.2008.04.023","volume":"31","author":"KC Fa\u00e9","year":"2008","unstructured":"Fa\u00e9 KC, Diefenbach da Silva D, Bilate AM, Tanaka AC, Pomerantzeff PM, Kiss MH, Silva CA, Cunha-Neto E, Kalil J, Guilherme L (2008) PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J Autoimmun 31:136\u2013141","journal-title":"J Autoimmun"},{"key":"9362_CR93","doi-asserted-by":"crossref","unstructured":"Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council of Cardiovascular Disease in the Young of the American Heart Association (1992) Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. JAMA 268(15):2069\u20132073","DOI":"10.1001\/jama.268.15.2069"},{"key":"9362_CR94","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00059-011-3478-8","volume":"4","author":"B Maisch","year":"2011","unstructured":"Maisch B (2011) Cardiovascular disease in cancer patients\u2014only the tip of the iceberg? Herz 4:287\u2013289","journal-title":"Herz"},{"key":"9362_CR95","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pcad.2010.05.006","volume":"53","author":"G Curigliano","year":"2010","unstructured":"Curigliano G, Mayer EL, Burstein HJ, Winer EP, Goldhirsch A (2010) Cardiac toxicity from systemic cancer therapy: a comprehensive review. Prog Cardiovasc Dis 53:94\u2013104","journal-title":"Prog Cardiovasc Dis"},{"key":"9362_CR96","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00059-011-3470-3","volume":"4","author":"A Shi","year":"2011","unstructured":"Shi A, Moon M, Dawood S, McManus B, Liu PP (2011) Mechanisms and management of doxorubicin cardiotoxicity. Herz 4:296\u2013305","journal-title":"Herz"},{"key":"9362_CR97","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00059-011-3471-2","volume":"4","author":"A Wittig","year":"2011","unstructured":"Wittig A, Engenhart-Cabillic R (2011) Cardiac side effects of conventional and particle radiotherapy in cancer patients. Herz 4:311\u2013324","journal-title":"Herz"},{"key":"9362_CR98","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/eurheartj\/ehr165","volume":"32","author":"HP Schultheiss","year":"2011","unstructured":"Schultheiss HP, K\u00fchl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32:2616\u20132625","journal-title":"Eur Heart J"},{"key":"9362_CR99","first-page":"284","volume":"122","author":"SA Huber","year":"1986","unstructured":"Huber SA, Lodge PA (1986) Coxsackievirus B-3-myocarditis. Identification of different pathogenic mechanisms in DBA\/2 and Balb\/c mice. Am J Pathol 122:284\u2013291","journal-title":"Am J Pathol"},{"issue":"7","key":"9362_CR100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1006\/jmcc.1994.1108","volume":"26","author":"M Herzum","year":"1994","unstructured":"Herzum M, Ruppert V, Kuytz B, Jomaa H, Nakamura I, Maisch B (1994) Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J Mol Cell Cardiol 26(7):907\u2013913","journal-title":"J Mol Cell Cardiol"},{"key":"9362_CR101","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Honmg JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320\u20131323","journal-title":"Science"},{"key":"9362_CR102","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1073\/pnas.91.13.6245","volume":"91","author":"JM Bergelson","year":"1994","unstructured":"Bergelson JM, Chan M, Solomon KR, St John NF, Lin H, Finberg RW (1994) Decay accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 91:6245\u20136249","journal-title":"Proc Natl Acad Sci USA"},{"key":"9362_CR103","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/6543","volume":"5","author":"C Badorff","year":"1999","unstructured":"Badorff C, Lee GH, Lamphear BJ et al (1999) Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 5:320\u2013326","journal-title":"Nat Med"},{"key":"9362_CR104","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/CIRCULATIONAHA.105.536433","volume":"112","author":"K Fuse","year":"2005","unstructured":"Fuse K, Chan G, Liu Y, Gudgeon P, Husain M, Chen M, Yeh WC, Akira S, Liu PP (2005) Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 112:2276\u20132285","journal-title":"Circulation"},{"key":"9362_CR105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymeth.2006.07.009","volume":"41","author":"D Fairwheather","year":"2007","unstructured":"Fairwheather D, Rose NR (2007) Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41:118\u2013122","journal-title":"Methods"},{"key":"9362_CR106","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.4049\/jimmunol.178.11.6710","volume":"178","author":"S Frisancho-Kiss","year":"2007","unstructured":"Frisancho-Kiss S, Davis SE, Nyland JF, Frisancho JA, Chilakova D, Barrett MA, Rose NR, Fairweather D (2007) Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 178:6710\u20136714","journal-title":"J Immunol"},{"key":"9362_CR107","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4049\/jimmunol.139.3.913","volume":"139","author":"EK Godeny","year":"1987","unstructured":"Godeny EK, Gauntt CJ (1987) Murine natural killer cells limit coxsackievirus B3 replication. J Immunol 139:913\u2013918","journal-title":"J Immunol"},{"key":"9362_CR108","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.RES.67.2.360","volume":"67","author":"Y Seko","year":"1990","unstructured":"Seko Y, Tsuchimochi H, Nakamura T, Okumura K, Naito S, Imataka K, Fujii J, Takaku F, Yazaki Y (1990) Expression of major histocompatibility complex class I antigen in murine ventricular myocytes infected with Coxsackievirus B3. Cir Res 67:360\u2013367","journal-title":"Cir Res"},{"key":"9362_CR109","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1172\/JCI116333","volume":"91","author":"Y Seko","year":"1993","unstructured":"Seko Y, Matsuda H, Kato K, Hashimoto Y, Yagita H, Okumura K, Yazaki Y (1993) Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3. J Clin Invest 91:1327\u20131336","journal-title":"J Clin Invest"},{"key":"9362_CR110","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/01.CIR.89.5.2170","volume":"89","author":"Y Seko","year":"1994","unstructured":"Seko Y, Yagita H, Okumura K, Yazaki Y (1994) T-cell receptor V beta expression in infiltrating cells in murine hearts withs acute myocarditis caused by coxsackievirus B3. Circulation 89:2170\u20132175","journal-title":"Circulation"},{"key":"9362_CR111","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/01.RES.0000249405.13536.49","volume":"99","author":"SA Huber","year":"2006","unstructured":"Huber SA, Feldman AM, Sartini D (2006) Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ Res 99:1109\u20131116","journal-title":"Circ Res"},{"key":"9362_CR112","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/CIRCRESAHA.109.195230","volume":"105","author":"K Li","year":"2009","unstructured":"Li K, Xu W, Guo Q, Jiang Z, Wang P, Yue Y, Xiong S (2009) Differential macrophage polarization in male and female BALB\/c mice infected with coxsackievirus B3 defines susceptibility to viral myocardits. Circ Res 105:353\u2013364","journal-title":"Circ Res"},{"key":"9362_CR113","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/978-1-4684-4472-8_29","volume":"161","author":"SA Huber","year":"1983","unstructured":"Huber SA, Job LP (1983) Cellular immune mechanisms in Coxsackievirus group B, type 3 included myocarditis in BALB\/C mice. Adv Exp Biol 161:491\u2013508","journal-title":"Adv Exp Biol"},{"key":"9362_CR114","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.CIR.97.7.637","volume":"97","author":"Y Seko","year":"1998","unstructured":"Seko Y, Takahashi N, Ishiyama S, Nishikawa T, Kasajima T, Hiroe M, Suzuki S, Ishiwata S, Kawai S, Azumu M et al (1998) Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy. Circulation 97:637\u2013639","journal-title":"Circulation"},{"key":"9362_CR115","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1253\/circj.68.677","volume":"68","author":"S Takata","year":"2004","unstructured":"Takata S, Nakamura H, Umemoto S, Yamaguchi K, Sekine T, Kato T, Nishioka K, Matsuzaki M (2004) Identification of autoantibodies with the corresponding antigen for repetitive coxsackievirus infection-induce cardiomyopathy. Circ J 68:677\u2013682","journal-title":"Circ J"},{"key":"9362_CR116","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0735-1097(93)90546-D","volume":"22","author":"N Latif","year":"1993","unstructured":"Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH (1993) Frequency and specifity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol 22:1378\u20131384","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR117","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/clim.1998.4679","volume":"91","author":"N Latif","year":"1999","unstructured":"Latif N, Zhang H, Archard LC, Yacoub MH, Dunn MJ (1999) Characterization of anti-heart antibodies in mice after infection with coxsackie B3 virus. Clin Immunol 91:90\u201398","journal-title":"Clin Immunol"},{"key":"9362_CR118","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","volume":"350","author":"NS Young","year":"2004","unstructured":"Young NS, Brown KE (2004) Mechanisms of disease. Parvovirus B19. N Engl J Med 350:586\u2013597","journal-title":"N Engl J Med"},{"key":"9362_CR119","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3476(05)80677-8","volume":"116","author":"I Saint-Martin","year":"1990","unstructured":"Saint-Martin I, Choulot JJ, Bonnau E, Morinet F (1990) Myocarditis caused by parvovirus. J Pediatr 116:1007\u20131008","journal-title":"J Pediatr"},{"key":"9362_CR120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/313929","volume":"13","author":"G Nigro","year":"2000","unstructured":"Nigro G, Bastianon V, Colloridl V et al (2000) Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 13:65\u201369","journal-title":"Clin Infect Dis"},{"key":"9362_CR121","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1161\/01.CIR.96.10.3549","volume":"96","author":"KO Schowengerdt","year":"1997","unstructured":"Schowengerdt KO, Ni J, Denfield SW et al (1997) Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 96:3549\u20133554","journal-title":"Circulation"},{"issue":"7","key":"9362_CR122","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0046-8177(03)00235-1","volume":"34","author":"S Lamparter","year":"2003","unstructured":"Lamparter S, Schoppet M, Pankuweit S, Maisch B (2003) Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol 34(7):725\u2013728","journal-title":"Hum Pathol"},{"key":"9362_CR123","first-page":"213","volume":"362","author":"CT Bock","year":"2010","unstructured":"Bock CT, Klingel K, Kandolf R (2010) Human parvovirus B19-associated myocarditis. N Engl J Med 362:213\u2013214","journal-title":"N Engl J Med"},{"issue":"4776","key":"9362_CR124","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.2876520","volume":"234","author":"SZ Salahuddin","year":"1986","unstructured":"Salahuddin SZ (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234(4776):596\u2013601","journal-title":"Science"},{"key":"9362_CR125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000073205","volume":"46","author":"GRF Krueger","year":"2003","unstructured":"Krueger GRF, Ablashi DV (2003) Human herpesvirus-6: a short review of its biological behavior. Intervirology 46:257\u2013269","journal-title":"Intervirology"},{"key":"9362_CR126","volume-title":"Human Herpesvirus-6 (Chapter 18)","author":"LM Buja","year":"2006","unstructured":"Buja LM (2006) HHV-6 in cardiovascular pathology. In: Krueger GRF, Ablashi DV (eds) Human Herpesvirus-6 (Chapter 18), 2nd edn. Elsevier, Amsterdam","edition":"2"},{"key":"9362_CR127","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2169\/internalmedicine.39.632","volume":"39","author":"S Fukae","year":"2000","unstructured":"Fukae S, Ashizawa N, Morikawa S, Yano K (2000) A fatal fulminant myocarditis with human herpesvirus-6 infection. Intern Med 39:632\u2013636","journal-title":"Intern Med"},{"key":"9362_CR128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0041-1345(01)02672-0","volume":"34","author":"M Ona De","year":"2002","unstructured":"De Ona M, Melon S, Rodriguez JL, Sanmartin JC, Bernardo MJ (2002) Association between human herpervirus type 6 and type 7, and cytomegalovirus disease in heart transplant recipients. Transpl Proc 34:75\u201376","journal-title":"Transpl Proc"},{"issue":"Suppl. 1","key":"9362_CR129","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S1386-6532(06)70010-5","volume":"37","author":"AL Komaroff","year":"2006","unstructured":"Komaroff AL (2006) Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol 37(Suppl. 1):S39\u2013S46","journal-title":"J Clin Virol"},{"key":"9362_CR130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/clin.1993.1123","volume":"68","author":"U Sch\u00f6nian","year":"1993","unstructured":"Sch\u00f6nian U, Crombach M, Maisch B (1993) Assessment of cytomegalovirus DNA and protein expression in patients with myocarditis. Clin Immol Immunopath 68:229\u2013233","journal-title":"Clin Immol Immunopath"},{"issue":"Suppl. D","key":"9362_CR131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/12.suppl_D.65","volume":"12","author":"U Sch\u00f6nian","year":"1991","unstructured":"Sch\u00f6nian U, Crombach M, Maisch B (1991) Does CMV infection play a role in myocarditis? New aspects from in situ hybridization. Eur Heart J 12(Suppl. D):65\u201368","journal-title":"Eur Heart J"},{"issue":"7","key":"9362_CR132","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/labinvest.3780120","volume":"80","author":"A Matsumori","year":"2000","unstructured":"Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S (2000) Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 80(7):1137\u20131142","journal-title":"Lab Invest"},{"issue":"9","key":"9362_CR133","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.100.9.933","volume":"100","author":"G Barbaro","year":"1999","unstructured":"Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Grisorio B, Pellicelli A, Barbarini G (1999) Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). Circulation 100(9):933\u2013939","journal-title":"Circulation"},{"key":"9362_CR134","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0735-1097(91)90493-S","volume":"18","author":"EB Liebermann","year":"1991","unstructured":"Liebermann EB, Hutchin GM, Herskowitz A et al (1991) Clinico-pathologic description of myocarditis. J Am Coll Cardiol 18:1617\u20131626","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR135","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","volume":"53","author":"MG Friedrich","year":"2009","unstructured":"Friedrich MG, Sechtem U, Schulz-Menger J et al (2009) For the international consensus group on cardiovascular magnetic resonance in myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 53:1475\u20131487","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR136","unstructured":"Maisch B, Alter P, Romminger M, Moll R, Baandrup U, Pankuweit S (2011) MRI or EMB for the diagnosis of myocarditis and viral heart disease EHJ suppl (Abstract supplement of the ESC Congress)"},{"key":"9362_CR137","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.CIR.0000118493.13323.81","volume":"109","author":"H Mahrholdt","year":"2004","unstructured":"Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109:1250\u20131258","journal-title":"Circulation"},{"issue":"7","key":"9362_CR138","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ehj.2004.02.002","volume":"25","author":"B Maisch","year":"2004","unstructured":"Maisch B, Seferovic PM, Ristic AD et al (2004) Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J 25(7):587\u2013610","journal-title":"Eur Heart J"},{"key":"9362_CR139","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-11335-2","volume-title":"Interventional Pericardiology- Pericardiocentesis, pericardioscopy, pericardial biopsy, balloon pericardiotomy and intrapericardial therapy","author":"B Maisch","year":"2011","unstructured":"Maisch B, Ristic AD, Seferovic PM, Tsang TSM (2011) Interventional Pericardiology- Pericardiocentesis, pericardioscopy, pericardial biopsy, balloon pericardiotomy and intrapericardial therapy. Springer, Heidelberg"},{"key":"9362_CR140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.CIR.50.2.239","volume":"50","author":"MDS Horowitz","year":"1974","unstructured":"Horowitz MDS, Schultz CS, Stinson EB et al (1974) Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation 50:239\u2013245","journal-title":"Circulation"},{"key":"9362_CR141","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/CIRCULATIONAHA.105.589663","volume":"113","author":"KL Baughman","year":"2006","unstructured":"Baughman KL (2006) Diagnosis of myocarditis: death of Dallas criteria. Circulation 113:593\u2013595","journal-title":"Circulation"},{"key":"9362_CR142","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/eurheartj\/16.suppl_O.173","volume":"16","author":"B Maisch","year":"1995","unstructured":"Maisch B, Hufnagel G, Sch\u00f6nian U, Hengstenberg C (1995) The European study of epidemiology and treatment of cardiac inflammatory disease (ESETCID). Eur Heart J 16:173\u2013175","journal-title":"Eur Heart J"},{"key":"9362_CR143","first-page":"376","volume":"4","author":"GE Burch","year":"1972","unstructured":"Burch GE (1972) Prolonged bed rest in the management of patients with cardiomyopathy. Cardiovasc Clin 4:376\u2013387","journal-title":"Cardiovasc Clin"},{"key":"9362_CR144","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1378\/chest.60.5.424","volume":"60","author":"GE Burch","year":"1971","unstructured":"Burch GE, McDonald CD (1971) Prolonged bed rest in the treatment of ischemic cardiomyopathy. Chest 60:424\u2013430","journal-title":"Chest"},{"key":"9362_CR145","unstructured":"Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation, Management of Heart Failure) (2005) ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). JACC 46(6):e1\u2013e82"},{"key":"9362_CR146","doi-asserted-by":"crossref","unstructured":"Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CM (2009) 2009 Fucussed update incorporated into the ACC\/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 53:e31\u2013e90","DOI":"10.1016\/j.jacc.2008.11.013"},{"key":"9362_CR147","doi-asserted-by":"crossref","unstructured":"Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Howes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellermans I, Krsitensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL (2008) ESC Guidelines for the eidagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC(HFA) and endorsed by the European Society of Intensiv Cardiac Care Medicine (ESICM). Eur Heart J 29:2388\u20132442","DOI":"10.1093\/eurheartj\/ehn309"},{"key":"9362_CR148","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","volume":"20","author":"M Packer","year":"1992","unstructured":"Packer M (1992) The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20:248\u2013254","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR149","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","unstructured":"CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril-Survival Study (CONSENSUS). N Engl J Med 316:1429\u20131435","journal-title":"N Engl J Med"},{"key":"9362_CR150","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA et al (1992) Effect of captopril on mortality and morbidity in patients with lef ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 327:669\u2013677","journal-title":"N Engl J Med"},{"key":"9362_CR151","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","volume":"327","author":"SOLVD Investigators","year":"1992","unstructured":"SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685\u2013691","journal-title":"N Engl J Med"},{"key":"9362_CR152","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","volume":"100","author":"M Packer","year":"1999","unstructured":"Packer M, Poole-Wilson PA, Armstrong PW et al (1999) Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100:2312\u20132318","journal-title":"Circulation"},{"key":"9362_CR153","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study (HOPE) investigators. N Engl J Med 342:145\u2013153","journal-title":"N Engl J Med"},{"key":"9362_CR154","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","volume":"362","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, Swedberg K, Granger CB et al (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall program. Lancet 362:759\u2013766","journal-title":"Lancet"},{"key":"9362_CR155","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K et al (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362:777\u2013781","journal-title":"Lancet"},{"key":"9362_CR156","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","volume":"355","author":"B Pitt","year":"2000","unstructured":"Pitt B, Poole-Wilson PA, Segal R et al (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial. The Losartan heart failure survaival study ELITE II. Lancet 355:1582\u20131587","journal-title":"Lancet"},{"key":"9362_CR157","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9149(97)89320-4","volume":"77","author":"SH Rezkalla","year":"1996","unstructured":"Rezkalla SH, Raikar S, Kloner RA (1996) Treatment of viral myocarditis with focus on captopril. Am J Cardiol 77:634\u2013637","journal-title":"Am J Cardiol"},{"key":"9362_CR158","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10557-007-6024-4","volume":"21","author":"S Saegusa","year":"2007","unstructured":"Saegusa S, Fei Y, Takahashi T, Sumino H, Moriya J, Kawaura K, Ymakawa J, Itoh T, Morimotio S, Nakahshi T, Iwai K, Matsumoto M, Kanda T (2007) Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression. Cardiovasc Drugs Ther 21:155\u2013160","journal-title":"Cardiovasc Drugs Ther"},{"key":"9362_CR159","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG (1991) Pathogical hypertrophy and cardiac insterstitium. Fibrosis and rennin-angiotensin-aldosterone system. Circulation 83:1849\u20131865","journal-title":"Circulation"},{"issue":"3","key":"9362_CR160","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00059-006-2823-9","volume":"31","author":"B Maisch","year":"2006","unstructured":"Maisch B, Rupp H (2006) Myocardial fibrosis: a cardiopathophysiologic Janus head. Herz 31(3):260\u2013268","journal-title":"Herz"},{"key":"9362_CR161","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/hrt.37.10.1022","volume":"37","author":"F Waagstein","year":"1975","unstructured":"Waagstein F, Hjalmarson A, Varnauskas E, Walentin L (1975) Effect of beta-adrenergic receptor blockade in congestive cardiomyoapthy. Br Heart J 37:1022\u20131036","journal-title":"Br Heart J"},{"key":"9362_CR162","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/hrt.44.2.134","volume":"44","author":"K Swedberg","year":"1980","unstructured":"Swedberg K, Hjalmarson A, Waagstein F, Wallentin I (1980) Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart J 44:134\u2013142","journal-title":"Br Heart J"},{"key":"9362_CR163","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group","year":"1999","unstructured":"MERIT-HF Study Group (1999) Effect of metoprolo CR\/XL in chronic heart failure. Metprolol CR\/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lanceat 353:2001\u20132007","journal-title":"Lanceat"},{"key":"9362_CR164","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS-II Investigators and Committee","year":"1999","unstructured":"CIBIS-II Investigators and Committee (1999) The cardiac insufficiency bisoprolol study II (CIBIS-II): a radomised trial. Lancet 353:9\u201313","journal-title":"Lancet"},{"key":"9362_CR165","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer M, Coats AJ, Fowler MB et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651\u20131658","journal-title":"N Engl J Med"},{"key":"9362_CR166","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709\u2013717","journal-title":"N Engl J Med"},{"key":"9362_CR167","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309\u20131321","journal-title":"N Engl J Med"},{"key":"9362_CR168","doi-asserted-by":"crossref","unstructured":"Swedberg K, Komjada M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, on behalf of the SHIFT Investigators (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875\u2013885","DOI":"10.1016\/S0140-6736(10)61198-1"},{"key":"9362_CR169","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","volume":"336","author":"Digitalis Investigation Group","year":"1997","unstructured":"Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336:525\u2013533","journal-title":"N Engl J Med"},{"key":"9362_CR170","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(85)80312-0","volume":"6","author":"MR Costanzo-Nordin","year":"1985","unstructured":"Costanzo-Nordin MR, Reap EA, Robinson JA, Scanlon PJ (1985) A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. J Am Coll Cardiol 6:1078\u20131082","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR171","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"Cardiac Arrhythmia Suppression Trial","year":"1989","unstructured":"Cardiac Arrhythmia Suppression Trial (1989) Increase mortality due to encainide or flecainide in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406\u2013412","journal-title":"N Engl J Med"},{"key":"9362_CR172","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)05281-1","volume":"350","author":"Amiodarone Trials Meta-Analysis Investigators","year":"1997","unstructured":"Amiodarone Trials Meta-Analysis Investigators (1997) Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomized trials. Lancet 350:1417\u20131424","journal-title":"Lancet"},{"key":"9362_CR173","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225\u2013237","journal-title":"N Engl J Med"},{"key":"9362_CR174","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","volume":"356","author":"SH Hohenloser","year":"2000","unstructured":"Hohenloser SH, Kuck KH, for the PIAF Investigators (2000) Rhythm or rate control in atrial fibrillation: pharmacological Intervention in Atrial Fibrillation(PIAF). A randomized trial. Lancet 356:1789\u20131794","journal-title":"Lancet"},{"key":"9362_CR175","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","volume":"41","author":"J Carlsson","year":"2003","unstructured":"Carlsson J, Miketic S, Windeler J et al (2003) Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation. The strategies of treatment of atrial fibrillation (STAF) study. J Am Coll Cardiol 41:1690\u20131696","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR176","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","volume":"347","author":"IC Gelder Van","year":"2002","unstructured":"Van Gelder IC, Hagens VE, Bosker HA et al (2002) Rate control versus electrical cardioversion for persistent atrial fibrillation study group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834\u20131840","journal-title":"N Engl J Med"},{"key":"9362_CR177","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"DG Wyse","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP et al (2002) For the Atrial Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825\u20131833","journal-title":"N Engl J Med"},{"issue":"23","key":"9362_CR178","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.0000100721.52503.85","volume":"108","author":"W Grimm","year":"2003","unstructured":"Grimm W, Christ M, Bach J, Muller HH, Maisch B (2003) Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 108(23):2883\u20132891","journal-title":"Circulation"},{"issue":"3","key":"9362_CR179","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00059-004-2578-0","volume":"29","author":"W Grimm","year":"2004","unstructured":"Grimm W, Alter P, Maisch B (2004) Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT. Herz 29(3):348\u2013352","journal-title":"Herz"},{"key":"9362_CR180","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","volume":"350","author":"A Kadish","year":"2005","unstructured":"Kadish A, Dyer A, Daubert JP, Quigg R, Estes M (2005) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyoapthy. N Engl J Med 350:2151\u20132158","journal-title":"N Engl J Med"},{"key":"9362_CR181","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(03)01042-8","volume":"42","author":"SL Higgins","year":"2003","unstructured":"Higgins SL, Hummel JD, Niazi IK et al (2003) Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42:1454\u20131459","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR182","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140\u20132150 (COMPANION)","journal-title":"N Engl J Med"},{"key":"9362_CR183","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0735-1097(02)01932-0","volume":"40","author":"C Linde","year":"2002","unstructured":"Linde C, Leclercq C, Rex S et al (2002) Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation In Cardiomyopathy(MUSTIC) study. J Am Coll Cardiol 40:111\u2013118","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR184","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/01.CIR.0000065226.24159.E9","volume":"107","author":"MG St John Sutton","year":"2003","unstructured":"St John Sutton MG, Plappert T, Abraham WT et al (2003) Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107:1985\u20131990","journal-title":"Circulation"},{"key":"9362_CR185","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/s-2001-16579-1","volume":"126","author":"BE Strauer","year":"2001","unstructured":"Strauer BE, Brehm M, Zeus T, Gattermann N, Hernandez A, Sorg RV, K\u00f6gler G, Wernet P (2001) Intrakoronare, humane autologe Stammzelltransplantation zur Myokard-Regeneration nach Herzinfarkt [Myocardial regeneration after intracoronary transplantation of human autologous stem cells following acute myocardial infarction]. Dtsch Med Wschr 126:932\u2013938","journal-title":"Dtsch Med Wschr"},{"key":"9362_CR186","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2006.07.057","volume":"48","author":"S Seth","year":"2006","unstructured":"Seth S, Narang R, Bhargava B et al (2006) for the AIIMS Cardiovascular Stem Cell Study Group. Percutaneous intracoronary cellular cardiomyoblasty for non-ischemic cardiomyopathy. Clinical and histopathological results. The first-in-man ABCD (Autologous Bone marrow Cells in Dilated cardiomyopathy) trial. J Am Coll Cardiol 48:2350\u20132351","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR187","first-page":"23","volume":"15","author":"CM Schannwell","year":"2008","unstructured":"Schannwell CM, K\u00f6stering M, Zeus T, Brehm M, Erdmann G, Fleissner T, Yousef M, K\u00f6gler G, Wernet P, Strauer BE (2008) Humane autologe intrakoronare Stammzelltransplantation zur Myokardregeneration bei dilatativer Kardiomyopathie(NYHA Stadium II bis III) [Autologous bone marrow cells in dilated cardiomyoapthy trial, D\u00fcsseldorfer ABCD Study)]. J Kardiol 15:23\u201330","journal-title":"J Kardiol"},{"key":"9362_CR188","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00059-004-2628-7","volume":"29","author":"B Maisch","year":"2004","unstructured":"Maisch B, Hufnagel G, K\u00f6lsch S et al (2004) Treatment of inflammatory dilated cardiomyopathy and myocarditis with immunosuppression and i.v. immunoglobulins. Herz 29:624\u2013636","journal-title":"Herz"},{"issue":"9","key":"9362_CR189","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00059-006-2941-4","volume":"31","author":"B Maisch","year":"2006","unstructured":"Maisch B, Richter A, Koelsch S et al (2006) Management of patients with suspected (peri-)myocarditis and inflammatory dilated cardiomyopathy. Herz 31(9):881\u2013890","journal-title":"Herz"},{"key":"9362_CR190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01995636","volume":"182","author":"S Saltykow","year":"1905","unstructured":"Saltykow S (1905) \u00dcber diffuse Myokarditis. Virchows Archiv f\u00fcr Pathologische Anatomie 182:1\u201339","journal-title":"Virchows Archiv f\u00fcr Pathologische Anatomie"},{"key":"9362_CR191","first-page":"402","volume":"6","author":"H Ren","year":"1993","unstructured":"Ren H, Poston RS, Hruban RH et al (1993) Long survival with giant cell myocarditis. Mod Pathol 6:402\u2013407","journal-title":"Mod Pathol"},{"key":"9362_CR192","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1378\/chest.117.3.905","volume":"117","author":"A Frustaci","year":"2000","unstructured":"Frustaci A, Chimenti C, Peironi M et al (2000) Giant cell myocarditis responding to immunosuppressive therapy. Chest 117:905\u2013907","journal-title":"Chest"},{"key":"9362_CR193","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199706263362603","volume":"336","author":"LT Cooper","year":"1997","unstructured":"Cooper LT, Berry GJ, Shabetai R (1997) Idiopathic giant cell myocarditis. Natural history and treatment. N Engl J Med 336:1860\u20131866","journal-title":"N Engl J Med"},{"key":"9362_CR194","first-page":"463","volume":"3","author":"L Cooper","year":"2001","unstructured":"Cooper L, Okura Y (2001) Idiopathic giant cell myocarditis. Current treatment options. Cardiovasc Med 3:463\u2013467","journal-title":"Cardiovasc Med"},{"key":"9362_CR195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02072354","volume":"1","author":"R Okada","year":"1985","unstructured":"Okada R, Wakafuji S (1985) Myocarditis in autopsy. Heart Vessels Suppl 1:23\u201329","journal-title":"Heart Vessels Suppl"},{"key":"9362_CR196","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0090-1229(90)90039-S","volume":"57","author":"M Kodama","year":"1990","unstructured":"Kodama M, Matsumoto Y, Fujiwara M et al (1990) A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57:250\u2013262","journal-title":"Clin Immunol Immunopathol"},{"key":"9362_CR197","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/01.RES.75.2.278","volume":"75","author":"M Kodama","year":"1994","unstructured":"Kodama M, Hanawa H, Saeki M et al (1994) Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 75:278\u2013284","journal-title":"Circ Res"},{"key":"9362_CR198","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/jmcc.1996.0293","volume":"29","author":"Y Okura","year":"1997","unstructured":"Okura Y, Yamamoto T, Goto S et al (1997) Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol 29:491\u2013502","journal-title":"J Mol Cell Cardiol"},{"key":"9362_CR199","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4419-9264-2_6","volume-title":"Cardiomyopathies and Heart Failure","author":"T Izumi","year":"2003","unstructured":"Izumi T, Takehana H, Kohno K, Nishii M, Takeuchi I, Nakano H, Koitabashi T, Inomata T (2003) Myosin autoreactive T cells and autoimmune myocarditis. Lessons from the disease caused by cardiac myosin peptide CM2. In: Matsumori A (ed) Cardiomyopathies and Heart Failure. Kluwer, Dordrecht, pp 59\u201365"},{"key":"9362_CR200","first-page":"227","volume":"4","author":"LT Cooper","year":"1997","unstructured":"Cooper LT, Berry GHJ, Shabetai R (1997) Giant cell myocarditis: distinctions from lymphocytic myocarditis and cardiac sarcoidosis. J Heart Fail 4:227\u2013230","journal-title":"J Heart Fail"},{"key":"9362_CR201","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/eurheartj\/8.suppl_J.271","volume":"Suppl. I","author":"M Costanzo-Nordin","year":"1987","unstructured":"Costanzo-Nordin M, Silver M, O\u2019Connell J et al (1987) Giant cell myocarditis: dramatic hemodynamic and histologic improvement with immunosuppressive therapy. Eur Heart J Suppl. I:271\u2013274","journal-title":"Eur Heart J"},{"key":"9362_CR202","first-page":"788","volume":"8","author":"V Desjardins","year":"1992","unstructured":"Desjardins V, Pelletier G, Leung TK et al (1992) Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis. Can J Cardiol 8:788\u2013792","journal-title":"Can J Cardiol"},{"key":"9362_CR203","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1155\/2001\/954340","volume":"15","author":"C Nash","year":"2001","unstructured":"Nash C, Panaccione R, Sutherland L et al (2001) Giant cell myocarditis in a patient with Crohn\u2019s disease, treated with Etanercept-a tumor necrosis factor-alpha antagonist. Can J Gastroenterol 15:607\u2013611","journal-title":"Can J Gastroenterol"},{"key":"9362_CR204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1053-2498(98)00014-X","volume":"18","author":"E Brilakis","year":"1999","unstructured":"Brilakis E, Olson LJ, Daly RC et al (1999) Role of ventricular assist device support as a bridge to transplantation in giant cell myocarditis. J Heart Lung Transp 18:31","journal-title":"J Heart Lung Transp"},{"key":"9362_CR205","first-page":"155","volume":"12","author":"SC Grant","year":"1993","unstructured":"Grant SC (1993) Recurrent giant cell myocarditis after transplantation. J Heart Lung Transpl 12:155\u2013156","journal-title":"J Heart Lung Transpl"},{"key":"9362_CR206","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1053-2498(00)00314-4","volume":"20","author":"R Scott","year":"2001","unstructured":"Scott R, Ratliff N, Starling R et al (2001) Recurrence of giant cell myocarditis in cardiac allograft. J Heart Lung Transpl 20:375\u2013380","journal-title":"J Heart Lung Transpl"},{"key":"9362_CR207","doi-asserted-by":"crossref","first-page":"251A","DOI":"10.1016\/S0735-1097(97)84799-7","volume":"29","author":"LT Cooper","year":"1998","unstructured":"Cooper LT, Berry GJ, Tazelaar H et al (1998) A comparison of post-transplantation survival in giant cell myocarditis and cardiomyopathy patients. J Am Coll Cardiol 29:251A","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR208","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","volume":"41","author":"Y Okura","year":"2003","unstructured":"Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, Bailey KR, Cooper LT (2003) A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 41:322\u2013328","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. I","key":"9362_CR209","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/eurheartj\/8.suppl_J.59","volume":"8","author":"G Hufnagel","year":"1987","unstructured":"Hufnagel G, Maisch B (1987) Pfeiffer U (1987) Immunhistologic investigations in suspected cardiac sarcoidosis. Eur Heart J 8(Suppl. I):59\u201362","journal-title":"Eur Heart J"},{"key":"9362_CR210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1253\/jcj.44.249","volume":"44","author":"M Sekiguchi","year":"1980","unstructured":"Sekiguchi M, Numao Y, Imai M et al (1980) Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis. Jpn Circ J 44:249\u2013263","journal-title":"Jpn Circ J"},{"issue":"12","key":"9362_CR211","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/hc1202.104524","volume":"105","author":"M Schoppet","year":"2002","unstructured":"Schoppet M, Pankuweit S, Moll R, Baandrup U, Maisch B (2002) Images in cardiovascular medicine. Phenotype of infiltrating T lymphocytes in cardiac sarcoidosis. Circulation 105(12):e67\u2013e68","journal-title":"Circulation"},{"key":"9362_CR212","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.5858\/2003-127-1207-CSCPIT","volume":"127","author":"M Schoppet","year":"2003","unstructured":"Schoppet M, Pankuweit S, Maisch B (2003) Cardiac sarcoidosis. Cytokine patterns in the course of the disease. Arch Pathol Lab Med 127:1207\u20131210","journal-title":"Arch Pathol Lab Med"},{"key":"9362_CR213","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1519","volume":"37","author":"R Valentonye","year":"2005","unstructured":"Valentonye R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A, Nagy M, Gaede KI, Franke A, Haesler R, Koch A, Lengauer T, Seegert D, Reiling N, Ehlers S, Schwinger E, Platzer M, Krawczak M, M\u00fcller-Quernheim J, Sch\u00fcrmann M, Schreiber S (2005) Sarcoidosis is associated with a truncating splice mutant in BTNL2. Nat Genet 37:357\u2013364","journal-title":"Nat Genet"},{"issue":"2","key":"9362_CR214","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000105552","volume":"109","author":"T Meyer","year":"2008","unstructured":"Meyer T, Lauschke J, Ruppert V, Richter A, Pankuweit S, Maisch B (2008) Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein. Cardiology 109(2):117\u2013121","journal-title":"Cardiology"},{"key":"9362_CR215","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ahj.2004.10.006","volume":"150","author":"H Ardehali","year":"2005","unstructured":"Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL, Kasper EK (2005) A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 150:459\u2013463","journal-title":"Am Heart J"},{"key":"9362_CR216","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2003.07.024","volume":"97","author":"R Bargout","year":"2004","unstructured":"Bargout R, Kelly RF (2004) Sarcoid heart disease. Clinical course and treatment. Int J Cardiol 97:173\u2013182","journal-title":"Int J Cardiol"},{"key":"9362_CR217","unstructured":"L\u00f6ffler W (1936) Endocarditis parietalis fibroplastica mit Bluteosinophilie. Ein eigenartiges Krankheitsbild. Schweizerische medizinische Wochenschrift, Basel, 66:817\u2013820"},{"issue":"3","key":"9362_CR218","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/hrt.39.3.233","volume":"39","author":"CM Oakley","year":"1977","unstructured":"Oakley CM, Olsen GJ (1977) Eosinophilia and heart disease. Br Heart J 39(3):233\u2013237","journal-title":"Br Heart J"},{"issue":"4","key":"9362_CR219","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0033-0620(85)90008-8","volume":"27","author":"EG Olsen","year":"1985","unstructured":"Olsen EG, Spry CJ (1985) Relation between eosinophilia and endomyocardial disease. Prog Cardiovasc Dis 27(4):241\u2013254","journal-title":"Prog Cardiovasc Dis"},{"issue":"22","key":"9362_CR220","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM199011293232211","volume":"323","author":"JE Parrillo","year":"1990","unstructured":"Parrillo JE (1990) Heart disease and the eosinophil. N Engl J Med 323(22):1560\u20131561","journal-title":"N Engl J Med"},{"key":"9362_CR221","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0002-9343(79)90227-4","volume":"67","author":"JE Parrillo","year":"1979","unstructured":"Parrillo JE, Borer JS, Henry WL et al (1979) The cardiovascular manifestations of the hypereosinophilic syndrome. Am J Med 67:572\u2013582","journal-title":"Am J Med"},{"issue":"1","key":"9362_CR222","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-97-1-78","volume":"97","author":"AS Fauci","year":"1982","unstructured":"Fauci AS, Harley JB, Roberts WC et al (1982) NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97(1):78\u201392","journal-title":"Ann Intern Med"},{"issue":"8","key":"9362_CR223","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ajh.22062","volume":"86","author":"J Gotlib","year":"2011","unstructured":"Gotlib J (2011) World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. Am J Hematol 86(8):677\u2013688","journal-title":"Am J Hematol"},{"key":"9362_CR224","unstructured":"Maisch B, Baandrup U, Moll R, Pankuweit S (2009) Eosinophilic carditis is rare but not to be overlooked, EHJ Suppl XX, Abstract"},{"issue":"6","key":"9362_CR225","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.4049\/jimmunol.123.6.2925","volume":"123","author":"GJ Gleich","year":"1979","unstructured":"Gleich GJ, Frigas E, Loegering DA et al (1979) Cytotoxic properties of the eosinophil major basic protein. J Immunol 123(6):2925\u20132927","journal-title":"J Immunol"},{"issue":"8534","key":"9362_CR226","first-page":"643","volume":"1","author":"PC Tai","year":"1987","unstructured":"Tai PC, Ackerman SJ, Spry CJ et al (1987) Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1(8534):643\u2013647","journal-title":"Lancet"},{"issue":"689","key":"9362_CR227","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/pgmj.59.689.147","volume":"59","author":"CJ Spry","year":"1983","unstructured":"Spry CJ, Tai PC, Davies J (1983) The cardiotoxicity of eosinophils. Postgrad Med J 59(689):147\u2013153","journal-title":"Postgrad Med J"},{"issue":"4","key":"9362_CR228","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1172\/JCI116382","volume":"91","author":"A Slungaard","year":"1993","unstructured":"Slungaard A, Vercellotti GM, Tran T et al (1993) Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest 91(4):1721\u20131730","journal-title":"J Clin Invest"},{"issue":"4","key":"9362_CR229","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1164\/ajrccm\/147.4.901","volume":"147","author":"T Ohnishi","year":"1993","unstructured":"Ohnishi T, Kita H, Weiler D et al (1993) IL-5 is the predominant eosinophil-active cytokine in the antigen- induced pulmonary late-phase reaction. Am Rev Respir Dis 147(4):901\u2013907","journal-title":"Am Rev Respir Dis"},{"key":"9362_CR230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0002-9149(00)00841-9","volume":"86","author":"S Ommen","year":"2000","unstructured":"Ommen S, Seward J, Tajik A (2000) Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol 86:110\u2013113","journal-title":"Am J Cardiol"},{"key":"9362_CR231","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1540-8175.2006.00288.x","volume":"23","author":"R Shah","year":"2006","unstructured":"Shah R, Ananthasubramaniam K (2006) Evaluation of cardiac involvement in hypereosinophilic syndrome: complementary roles of transthoracic, transesophageal, and contrast echocardiography. Echocardiography 23:689\u2013691","journal-title":"Echocardiography"},{"key":"9362_CR232","unstructured":"Del Bene MR, Cappelli F, Rega L, Venditti F, Barletta G (2011) Characterization of Loeffler Eosinophilic Myocarditis by means of real time three-dimensional contrast-enhanced echocardiography. Echocardiography 19(3):E62\u2013E66"},{"key":"9362_CR233","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.ijcard.2007.01.019","volume":"126","author":"IS Syed","year":"2008","unstructured":"Syed IS, Martinez MW, Feng DL et al (2008) Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol 126:e50\u2013e52","journal-title":"Int J Cardiol"},{"issue":"1","key":"9362_CR234","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.ijcard.2009.03.059","volume":"149","author":"T Kleinfeldt","year":"2011","unstructured":"Kleinfeldt T, Ince H, Nienaber CA (2011) Hypereosinophilic syndrome: a rare case of Loeffler\u2019s endocarditis documented in cardiac MRI. Int J Cardiol 149(1):e30\u2013e32","journal-title":"Int J Cardiol"},{"issue":"5","key":"9362_CR235","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00246-007-9151-6","volume":"29","author":"A Paydar","year":"2008","unstructured":"Paydar A, Ordovas KG, Reddy GP (2008) Magnetic resonance imaging for endomyocardial fibrosis. Pediatr Cardiol 29(5):1004\u20131005","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"9362_CR236","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-10-21","volume":"10","author":"K Deb","year":"2008","unstructured":"Deb K, Djavidani B, Luchner A et al (2008) Time course of eosinophilic myocarditis visualized by CMR. J Cardiovasc Magn Reson 10(1):21\u201325","journal-title":"J Cardiovasc Magn Reson"},{"key":"9362_CR237","first-page":"8","volume":"5","author":"Y Uetsuka","year":"1990","unstructured":"Uetsuka Y, Kasahara S, Tanaka N et al (1990) Hemodynamic and scintigraphic improvement after steroid therapy in a case with acute eosinophilic heart disease. Heart Vessels Suppl 5:8\u201312","journal-title":"Heart Vessels Suppl"},{"issue":"9","key":"9362_CR238","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7326\/0003-4819-121-9-199411010-00003","volume":"121","author":"JH Butterfield","year":"1994","unstructured":"Butterfield JH, Gleich GJ (1994) Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med 121(9):648\u2013653","journal-title":"Ann Intern Med"},{"issue":"5","key":"9362_CR239","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2141.2008.07294.x","volume":"143","author":"G Metzgeroth","year":"2008","unstructured":"Metzgeroth G, Walz C, Reiter A et al (2008) Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome\u2014a phase-II study. Br J Haematol 143(5):707\u2013715","journal-title":"Br J Haematol"},{"issue":"4","key":"9362_CR240","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1586\/eci.11.27","volume":"7","author":"JP Abonia","year":"2011","unstructured":"Abonia JP, Putnam PE (2011) Mepolizumab in eosinophilic disorders. Expert Rev Clin Immunol 7(4):411\u2013417","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"9362_CR241","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jaci.2003.10.049","volume":"113","author":"JK Garrett","year":"2004","unstructured":"Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK et al (2004) Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113(1):115\u2013119","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"9362_CR242","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","volume":"358","author":"M Rothenberg","year":"2008","unstructured":"Rothenberg M, Klion A, Gleich G et al (2008) Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 358(12):1215\u20131228","journal-title":"N Engl J Med"},{"key":"9362_CR243","first-page":"419","volume":"57","author":"WD Edwards","year":"1982","unstructured":"Edwards WD, Holmes DR, Reeder GS (1982) Diagnosis of active lymphocytic myocarditis by endomyocardial biopsy. Quantitative criteria for light microscopy. Mayo Clin Proc 57:419\u2013425","journal-title":"Mayo Clin Proc"},{"key":"9362_CR244","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJM198301063080103","volume":"308","author":"JJ Fenoglio","year":"1983","unstructured":"Fenoglio JJ, Ursell PC, Kellogg CF, Drusin RE, Weiss MB (1983) Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 308:12\u201318","journal-title":"N Engl J Med"},{"key":"9362_CR245","doi-asserted-by":"crossref","unstructured":"Dec quoted in Batra AS, Lewis AB (2001) Acute myocarditis. Curr Opin Pediatr 13:234\u2013239 and in (186)","DOI":"10.1097\/00008480-200106000-00004"},{"key":"9362_CR246","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0735-1097(85)80485-X","volume":"6","author":"JD Hosenpud","year":"1985","unstructured":"Hosenpud JD, McAnulty JH, Niles NR (1985) Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. J Am Coll Cardiol 6:217\u2013222","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR247","unstructured":"Anderson quoted in Maisch B, Herzum M, Schoenian U (1993) Immunomodulating factors and immunosuppressive drugs in the therapy of myocarditis. Scand J Infect Dis Suppl 88:149\u201362. (=41) and in (187)"},{"key":"9362_CR248","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000157119","volume":"7","author":"CC Marboe","year":"1988","unstructured":"Marboe CC, Fenoglio JJ Jr (1988) Pathology and natural history of human myocarditis. Pathol Immunopathol Res 7:226\u2013239","journal-title":"Pathol Immunopathol Res"},{"key":"9362_CR249","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0002-8703(89)90626-1","volume":"117","author":"RD Latham","year":"1989","unstructured":"Latham RD, Mulrow JP, Virmani R et al (1989) Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy. Am Heart J 117:876\u2013882","journal-title":"Am Heart J"},{"issue":"Suppl. 1","key":"9362_CR250","first-page":"S29","volume":"70","author":"B Maisch","year":"1994","unstructured":"Maisch B, Schoenian U, Hengstenberg C, Herzum M, Hufnagel G, Bethge C, Bittinger A, Neumann K (1994) Immunosuppressive therapy in autoreactive myocarditis: results from a controlled trial. Postgrad Med J 70(Suppl. 1):S29\u2013S34","journal-title":"Postgrad Med J"},{"issue":"Suppl. 1","key":"9362_CR251","first-page":"S35","volume":"70","author":"U K\u00fchl","year":"1994","unstructured":"K\u00fchl U, Strauer BE, Schultheiss H-P (1994) Methylprednisolone in chronic myocarditis. Postgrad Med J 70(Suppl. 1):S35\u2013S42","journal-title":"Postgrad Med J"},{"key":"9362_CR252","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00796819","volume":"16","author":"PR Camargo","year":"1995","unstructured":"Camargo PR, Snitcowsky R, da Luz PL, Mazzieri R, Higuchi ML, Rati M et al (1995) Favourable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 16:61\u201368","journal-title":"Pediatr Cardiol"},{"key":"9362_CR253","first-page":"481","volume":"11","author":"Liu Dezue","year":"2002","unstructured":"Dezue Liu (2002) Observation of integrated Chinese traditional and Western medicine on acute viral myocarditis. Xian Dai Zhong Xi Yi Jie He Za Zhi 11:481\u2013482","journal-title":"Xian Dai Zhong Xi Yi Jie He Za Zhi"},{"key":"9362_CR254","first-page":"59","volume":"21","author":"Liu Dezue","year":"2003","unstructured":"Dezue Liu, Lei Yang, Haixia Jiang (2003) Clinical search of Sheng Mai Injection combined with corticosteroids for acute viral myocarditis in children. J Sichuan Tradit Chin Med 21:59\u201360","journal-title":"J Sichuan Tradit Chin Med"},{"key":"9362_CR255","first-page":"211","volume":"9","author":"Sun Dabao","year":"1999","unstructured":"Dabao Sun (1999) Corticosteroid treatment effects in 36 cases diagnose with viral myocarditis with ventricle premature beats. J Zhenjiang Med Coll 9:211","journal-title":"J Zhenjiang Med Coll"},{"key":"9362_CR256","first-page":"350","volume":"6","author":"Wu Yo-zang","year":"1999","unstructured":"Yo-zang Wu, Bing-wang Chen (1999) Observation on curative effects of astragalus injection combined with glucocorticoids on acutely severe viral myocarditis. Zhongguo Zhong Xe Yi Jie He Ji Jui Za Zhi 6:350\u20133521999","journal-title":"Zhongguo Zhong Xe Yi Jie He Ji Jui Za Zhi"},{"key":"9362_CR257","first-page":"513","volume":"21","author":"Kong Qing-fu","year":"2001","unstructured":"Qing-fu Kong, Shu-zhi Song, Xue-ying Xie, Xin-hua Zhang, Ge-jie Yue, Zhao-li Chen (2001) Clinical study on therapeutic effects of treatment according to syndrome differentiation of traditional chinese medicine combined with captopril on severe viral myocarditis complicated heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 21:513\u2013515","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"9362_CR258","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.CIR.0000048147.15962.31","volume":"107","author":"A Frustaci","year":"2003","unstructured":"Frustaci A, Calabrese F, Chimenti C, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile for responders versus nonresponders. Circulation 107:857\u2013863","journal-title":"Circulation"},{"key":"9362_CR259","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM198910193211601","volume":"321","author":"JE Parillo","year":"1989","unstructured":"Parillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, Palmeri S, Alling D, Wittes J, Ferrans VJ, Rodriguez AR, Fauci AS (1989) A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 321:1061\u20131068","journal-title":"N Engl J Med"},{"key":"9362_CR260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM199508033330501","volume":"33","author":"JW Mason","year":"1995","unstructured":"Mason JW, O\u2019Connel JB, Hershkowitz A, Rose NR, McManus BM, Billingham ME et al (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 33:269\u2013275","journal-title":"N Engl J Med"},{"key":"9362_CR261","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00001573-199605000-00014","volume":"11","author":"CA Brown","year":"1996","unstructured":"Brown CA, O\u2019Connel JB (1996) Implications of the myocarditis treatment trial for clinical practice. Curr Opin Cardiol 11:332\u2013336","journal-title":"Curr Opin Cardiol"},{"key":"9362_CR262","first-page":"1713","volume":"333","author":"B Maisch","year":"1955","unstructured":"Maisch B, Camerini F, Schultheiss H-P (1955) Immunosuppressive therapy for myocarditis (letter). N Engl J Med 333:1713","journal-title":"N Engl J Med"},{"key":"9362_CR263","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.CIR.104.1.39","volume":"104","author":"R Wojnicz","year":"2001","unstructured":"Wojnicz R, Nowalany-Koziolaska E, Wojciechowska C et al (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy. Two-year follow-up results. Circulation 104:39\u201345","journal-title":"Circulation"},{"key":"9362_CR264","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","volume":"30","author":"A Frustaci","year":"2009","unstructured":"Frustaci A, Russo MA, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30:1995\u20132002","journal-title":"Eur Heart J"},{"key":"9362_CR265","unstructured":"Maisch B, K\u00f6lsch S, Hufnagel G, Funck RC, Ruppert V, Pankuweit S for the ESETCID Investigators, Orlando 2011, AHA Congress, Abstract"},{"key":"9362_CR266","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","volume":"320","author":"RM Anthony","year":"2008","unstructured":"Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV (2008) Recapitulation of IVIG anti-inflammatory activity with a recombinant Ig Fc. Science 320:373\u2013376","journal-title":"Science"},{"key":"9362_CR267","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0091-6749(97)70217-3","volume":"100","author":"M Ballow","year":"1997","unstructured":"Ballow M (1997) Mechanisms of actin of intrvenous immune serum globulin in autoimmune and inflammatory diseases. J Allergy Clin Immunol 100:151\u2013157","journal-title":"J Allergy Clin Immunol"},{"key":"9362_CR268","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1001\/jama.291.19.2367","volume":"291","author":"MC Dalakas","year":"2004","unstructured":"Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular disease. JAMA 291:2367\u20132375","journal-title":"JAMA"},{"key":"9362_CR269","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","volume":"26","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn F, Ravetsch JV (2008) Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 26:513\u2013533","journal-title":"Annu Rev Immunol"},{"key":"9362_CR270","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","volume":"345","author":"MD Kzatchkine","year":"2001","unstructured":"Kzatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747\u2013755","journal-title":"N Engl J Med"},{"key":"9362_CR271","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1006\/clin.1993.1082","volume":"67","author":"FS Rosen","year":"1993","unstructured":"Rosen FS (1993) Putative mechanisms oft he effect of intravenous gamma-globulin. Clin Immunol Immunopathol 67:S41\u2013S43","journal-title":"Clin Immunol Immunopathol"},{"key":"9362_CR272","first-page":"119","volume":"74","author":"N Mobini","year":"1995","unstructured":"Mobini N, Sarela A, Ahmed AR (1995) Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders. Ann Allergy Asthma Immunol 74:119\u2013128","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9362_CR273","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ncpneuro0376","volume":"3","author":"R Gold","year":"2007","unstructured":"Gold R, Stangel M, Dalakas MC (2007) Drug insight: the use of intravenous immunoglobulin in neurology-therapeutic considerations and practical issues. Nat Clin Pract Neurol 3:36\u201344","journal-title":"Nat Clin Pract Neurol"},{"key":"9362_CR274","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(95)90569-3","volume":"345","author":"A Selbing","year":"1995","unstructured":"Selbing A, Josefsson A, Dahle LO, Lindgren R (1995) Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin. Lancet 345:660\u2013661","journal-title":"Lancet"},{"key":"9362_CR275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.CIR.103.2.220","volume":"103","author":"L Gullestad","year":"2001","unstructured":"Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Froland SS, Aukrust P (2001) Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 103:220\u2013225","journal-title":"Circulation"},{"issue":"1","key":"9362_CR276","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2006.05.015","volume":"112","author":"P Aukrust","year":"2006","unstructured":"Aukrust P, Yndestad A, Ueland T, Dam\u00e5s JK, Fr\u00f8land SS, Gullestad L (2006) The role of intravenous immunoglobulin in the treatment of chronic heart failure. Int J Cardiol 112(1):40\u201345","journal-title":"Int J Cardiol"},{"issue":"6","key":"9362_CR277","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2008.04.001","volume":"7","author":"N Udi","year":"2008","unstructured":"Udi N, Yehuda S (2008) Intravenous immunoglobulin\u2014indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7(6):445\u2013452","journal-title":"Autoimmun Rev"},{"issue":"2","key":"9362_CR278","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1399-3089.2003.00098.x","volume":"11","author":"AJ Walpen","year":"2004","unstructured":"Walpen AJ, Laumonier T, Aebi C, Mohacsi PJ, Rieben R (2004) IgM enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bacterial killing by human serum. Xenotransplantation 11(2):141\u2013148","journal-title":"Xenotransplantation"},{"issue":"18","key":"9362_CR279","first-page":"1405","volume":"100","author":"C Kishimoto","year":"1999","unstructured":"Kishimoto C, Fujita M, Kinoshita M, Iwase T, Fujii B, Murashige A et al (1999) Immunglobulin therapy for myocarditis an acute dilated cardiomyopathy. Circulation 100(18):1405","journal-title":"Circulation"},{"key":"9362_CR280","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-5273(03)00002-0","volume":"91","author":"C Kishimoto","year":"2003","unstructured":"Kishimoto C, Shioji K, Kinoshita M, Iwase T, Tamaki S, Jujii M, Murashige A, Maruhashi H, Takeda S, Nonogi H, Hashimoto T (2003) Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int J Cardiol 91:173\u2013178","journal-title":"Int J Cardiol"},{"key":"9362_CR281","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2261-5-12","volume":"5","author":"J Robinson","year":"2005","unstructured":"Robinson J, Hartling L, Crumley E, Vandermeer B, Klassen TP (2005) A systematic review of intravenous gamma globulin for the therapy of acute myocarditis. BMC Cardiovasc Disord 5:12\u201318","journal-title":"BMC Cardiovasc Disord"},{"key":"9362_CR282","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0735-1097(99)00161-8","volume":"34","author":"B Bozkurt","year":"1999","unstructured":"Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ, MacGowan GA, Murali S, Rosenblum WD, Feldman AM, McNamara DM (1999) Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 34:177\u2013180","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR283","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1253\/jcj.62.871","volume":"62","author":"Y Takeda","year":"1998","unstructured":"Takeda Y, Yasuda S, Miyazaki S et al (1998) High-dose immunoglobulin G therapy for fulminant myocarditis. Jap Circ J 62:871\u2013872","journal-title":"Jap Circ J"},{"issue":"7","key":"9362_CR284","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0828-282X(08)70638-X","volume":"24","author":"S Goland","year":"2008","unstructured":"Goland S, Czer LSC, Siegel RJ, Tabak S, Jordan S, Luthringer D, Mirocha J, Coleman B, Kass RM, Trento A (2008) Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of sixpatients and review of literature. Can J Cardiol 24(7):571\u2013574","journal-title":"Can J Cardiol"},{"key":"9362_CR285","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.89.1.252","volume":"89","author":"NA Drucker","year":"1994","unstructured":"Drucker NA, Colan SD, Lewis AB et al (1994) Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89:252\u2013257","journal-title":"Circulation"},{"key":"9362_CR286","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1161\/01.CIR.95.11.2476","volume":"95","author":"DM McNamara","year":"1997","unstructured":"McNamara DM, Rosenblum WD, Janosko KM et al (1997) Intravenous immune gobulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 95:2476\u20132478","journal-title":"Circulation"},{"key":"9362_CR287","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.CIR.103.18.2254","volume":"103","author":"DM McNamara","year":"2001","unstructured":"McNamara DM, Holubkov R, Starling RC, Dec W, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, Mann DL (2001) for the Intervention in Myocarditis and Acute Cardiomyopathy (IMAC) Investigators. Controlled trial of intravenous immune globuline in recent-onset dilated cardiomyopathy. Circulation 103:2254\u20132259","journal-title":"Circulation"},{"key":"9362_CR288","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1253\/circj.66.977","volume":"66","author":"K Shioji","year":"2002","unstructured":"Shioji K, Matsuura Y, Iwase T et al (2002) Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thiredoxin\u2014a case report. Circulation J 66:977\u2013980","journal-title":"Circulation J"},{"key":"9362_CR289","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2796.2002.00929.x","volume":"251","author":"A Tedeschi","year":"2002","unstructured":"Tedeschi A, Liraghi L, Giannini S et al (2002) High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature. J Intern Med 251:169\u2013173","journal-title":"J Intern Med"},{"key":"9362_CR290","first-page":"311","volume":"42","author":"YG Tsai","year":"2001","unstructured":"Tsai YG, Ou TY, Wang CC et al (2001) Intravenous gamma-globulin therapy in myocarditis complicated with complete heart block: report of one case. Chung-Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Ts Chih 42:311\u2013313","journal-title":"Chung-Hua Min Kuo Hsiao Erh Ko I Hsueh Hui Ts Chih"},{"issue":"11","key":"9362_CR291","first-page":"1133","volume":"48","author":"K Shioji","year":"2000","unstructured":"Shioji K, Kishimoto C, Sasyama S (2000) Immunoglobulin therapy for acute myocarditis. Respiration&Circulation 48(11):1133\u20131139","journal-title":"Respiration&Circulation"},{"issue":"6","key":"9362_CR292","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1161\/01.CIR.92.6.1604","volume":"92","author":"H Takada","year":"1995","unstructured":"Takada H, Kishimoto C, Hiraoka Y (1995) Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model\u2014antiviral and anti-inflammatory effects. Circulation 92(6):1604\u20131611","journal-title":"Circulation"},{"key":"9362_CR293","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/313929","volume":"31","author":"G Nigro","year":"2000","unstructured":"Nigro G, Bastianon V, Coloridi V et al (2000) Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 31:65\u201369","journal-title":"Clin Infect Dis"},{"key":"9362_CR294","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3851\/IMP1516","volume":"15","author":"R Dennert","year":"2010","unstructured":"Dennert R, Velthuis S, Schalla S, Eurlings L, van Suylen R-J, van Paassen P, Tervaert JWC, Wolffs P, Goossens VJ, Bruggeman C, Waltenberger J, Crijns HJ, Heymans S (2010) Intravenous immunoglobulin therapy for patients with idiopathic cardiomyoapthy and endomyocardial biopsy-proven high PVB19 viral load. Antiviral Ther 15:193\u2013201","journal-title":"Antiviral Ther"},{"key":"9362_CR295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","volume":"23","author":"C Wang","year":"2004","unstructured":"Wang C, Luf FL, Wu M et al (2004) Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 23:275\u2013276","journal-title":"Pediatr Infect Dis J"},{"key":"9362_CR296","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00246-009-9589-9","volume":"31","author":"D Klugman","year":"2009","unstructured":"Klugman D, Berger JT, Sable CA, He J, Khandelwal SG, Sionim AD (2009) Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol 31:222\u2013228","journal-title":"Pediatr Cardiol"},{"key":"9362_CR297","unstructured":"Maisch B, Pankuweit S, Funck R, Koelsch S (2004) Effective CMV hyperimmunoglobulin treatment in CMV myocarditis\u2014a controled treatment trial. Eur Heart J 25:Abstract Suppl:114,P674.abstract"},{"key":"9362_CR298","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1136\/heart.85.1.e2","volume":"85","author":"P Alter","year":"2001","unstructured":"Alter P, Grimm W, Maisch B (2001) Varicella myocarditis in an adult. Heart 85:E2","journal-title":"Heart"},{"key":"9362_CR299","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1056\/NEJM200211283472220","volume":"347","author":"G Wallukat","year":"2002","unstructured":"Wallukat G, M\u00fcller J, Hetzer R (2002) Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 347:1806","journal-title":"N Engl J Med"},{"key":"9362_CR300","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0167-5273(96)02598-3","volume":"54","author":"G Wallukat","year":"1996","unstructured":"Wallukat G, Reinke P, Dorffel WV, Luther HP, Bestvater K, Felix SB, Baumann G (1996) Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 54:191\u2013195","journal-title":"Int J Cardiol"},{"key":"9362_CR301","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(00)00568-4","volume":"35","author":"SB Felix","year":"2000","unstructured":"Felix SB, Staudt A, Dorffel WV, Stangl V, Merkel K, Pohl M, Docke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35:1590\u20131598","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR302","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.CIR.101.4.385","volume":"101","author":"J M\u00fcller","year":"2000","unstructured":"M\u00fcller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385\u2013391","journal-title":"Circulation"},{"key":"9362_CR303","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(01)01113-X","volume":"423","author":"Y Staudt","year":"2003","unstructured":"Staudt Y, Mobini R, Fu M, Felix SB, Staudt A (2003) \u00df1-Adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol 423:115\u2013119","journal-title":"Eur J Pharmacol"},{"key":"9362_CR304","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0735-1097(01)01794-6","volume":"39","author":"SB Felix","year":"2002","unstructured":"Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, Wallukat G, Wernecke KD, Baumann G, Stangl K (2002) Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 39:646\u2013652","journal-title":"J Am Coll Cardiol"},{"key":"9362_CR305","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/01.CIR.0000036746.49449.64","volume":"106","author":"A Staudt","year":"2002","unstructured":"Staudt A, B\u00f6hm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB (2002) Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients suffering from dilated cardiomyopathy. Circulation 106:2448\u20132453","journal-title":"Circulation"},{"key":"9362_CR306","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/01.CIR.103.22.2681","volume":"103","author":"A Staudt","year":"2001","unstructured":"Staudt A, Schaper F, Stangl V, Plagemann A, B\u00f6hm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103:2681\u20132686","journal-title":"Circulation"},{"key":"9362_CR307","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2362.2010.02314.x","volume":"20","author":"Christiane Trimpert","year":"2010","unstructured":"Trimpert Christiane, Herda Lars R, Eckerle Lars G, Pohle Susanne, M\u00fcller Carina, Landsberger Martin, Felix Stephan B, Staudt Alexander (2010) Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies. Eur J Clin Invest 20:685\u2013691","journal-title":"Eur J Clin Invest"},{"key":"9362_CR308","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00109-007-0263-5","volume":"85","author":"A Kallwellis-Opara","year":"2007","unstructured":"Kallwellis-Opara A, Staudt A, Trimpert C, Noutsias M, K\u00fchl U, Pauschinger M, Schultheiss H-P, Grube M, B\u00f6hm M, Baumann G, V\u00f6lker U, Kroemer HK, Felix SB (2007) Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy. J Mol Med 85:1429\u20131435","journal-title":"J Mol Med"},{"key":"9362_CR309","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0264-410X(90)90098-7","volume":"8","author":"J Fohlman","year":"1990","unstructured":"Fohlman J et al (1990) Vaccination of Balb\/c mice against enteroviral mediated myocarditis. Vaccine 8:381\u2013384","journal-title":"Vaccine"},{"key":"9362_CR310","first-page":"103","volume":"88","author":"J Fohlmann","year":"1993","unstructured":"Fohlmann J, Pauksen K, Morein B, Bjare U, Ilb\u00e4ck N-G, Friman G (1993) High yield production of an inactivated Coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand J Infect Dis-Suppl 88:103\u2013108","journal-title":"Scand J Infect Dis-Suppl"},{"key":"9362_CR311","first-page":"109","volume":"88","author":"MA McKinlay","year":"1993","unstructured":"McKinlay MA (1993) Discovery and dvelopment of antipicornalaviral agents. Scand J Infect Dis 88:109\u2013115","journal-title":"Scand J Infect Dis"},{"key":"9362_CR312","first-page":"117","volume":"88","author":"N-G Ilb\u00e4ck","year":"1993","unstructured":"Ilb\u00e4ck N-G, Wesslen L, Pauksen K, Stalhadnske T, Friman G, Fohlman J (1993) Effects oft he antiviral WIN 54954 and the immune modulator LS 2616 on cachectin\/TNF and g-interferon responses during viral heart disease. Scand J Infect Dis 88:117\u2013123","journal-title":"Scand J Infect Dis"},{"key":"9362_CR313","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.0000072766.67150.51","volume":"107","author":"U K\u00fchl","year":"2003","unstructured":"K\u00fchl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W (2003) SchultheissHP. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventriclar function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793\u20132798","journal-title":"Circulation"},{"key":"9362_CR314","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/650700","volume":"201","author":"C Schmidt-Lucke","year":"2010","unstructured":"Schmidt-Lucke C, Spillmann F, Bock T, van Linthout S, K\u00fchl U, Schultheiss HP, Tschoepe C (2010) Interferon-beta modulates endothelial damage in patients with cardiac persistance of parvovirus B19. J Infect Dis 201:936\u2013945","journal-title":"J Infect Dis"},{"key":"9362_CR315","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","volume":"30","author":"HP Schultheiss","year":"2009","unstructured":"Schultheiss HP, Piper C, Sowade K, Karason JF, Kapp G, Groetzbach F, Waagstein E, Arbustini E, Siedentop H, K\u00fchl U (2009) The effect of subcutaneous treatment with interferon-beta1b over 24\u00a0weeks on safety, virus elimination and clinical outcome in patients with chronic viral cardiomyopathy. Eur Heart J 30:1995\u20132002","journal-title":"Eur Heart J"},{"issue":"19","key":"9362_CR316","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1053\/euhj.2002.3152","volume":"23","author":"B Maisch","year":"2002","unstructured":"Maisch B, Ristic AD, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23(19):1503\u20131508","journal-title":"Eur Heart J"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-012-9362-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-012-9362-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-012-9362-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T16:10:04Z","timestamp":1687882204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-012-9362-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,8]]},"references-count":316,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["9362"],"URL":"https:\/\/doi.org\/10.1007\/s10741-012-9362-7","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,8]]}}}